Jennifer Champoux
Chief Operating OfficerMs. Jennifer Champoux, also known as Jen, was Chief People & Operations Officer of Monte Rosa Therapeutics, Inc. from March 2023 until May 30, 2024 and serves as its Chief Operating Officer since May 30, 2024. She joined the Monte Rosa Therapeutics, Inc. in March 2021. She was Senior Vice President of Operations of Monte Rosa Therapeutics, Inc. from 2022 to March 2023 and served as its Vice President of Operations since March 2021 until 2022. She has operations experience in the biotech industry, including site operations, strategic planning, finance, communications and culture & employee engagement. Prior to joining Monte Rosa, she was Executive Director of Operations at H3 Biomedicine where she led the operations, communications and finance operations teams. She previously worked at Novartis Institutes for Biomedical Research where she led operations for the Discovery Chemistry group in Cambridge. She started her career in several pharmaceutical development functions, including process chemistry, program management and clinical operations at Merck and Array BioPharma. Ms. Champoux holds a B.S. in chemistry from University of Vermont and a M.S in organic chemistry from Indiana University.
Positions
- Company NameMonte Rosa Therapeutics, Inc.Stock CodeGLUEPositionChief Operating OfficerColleagues
- MWMarkus WarmuthPresident, CEO & Director
- ANAndrew Newman SchiffIndependent Chairman of the Board
- PNPhilip NicksonChief Business & Legal Officer
- FJFilip JankuChief Medical Officer
- MBMatthew BowenCorporate Controller & Principal Accounting Officer
- KLKimberly Lynn BlackwellIndependent Director
- CEChristine E. SiuIndependent Director
- JSJan SkvarkaIndependent Director
